Peter Cashin

1.6k total citations
42 papers, 623 citations indexed

About

Peter Cashin is a scholar working on Surgery, Emergency Medicine and Reproductive Medicine. According to data from OpenAlex, Peter Cashin has authored 42 papers receiving a total of 623 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Surgery, 33 papers in Emergency Medicine and 18 papers in Reproductive Medicine. Recurrent topics in Peter Cashin's work include Intraperitoneal and Appendiceal Malignancies (38 papers), Appendicitis Diagnosis and Management (33 papers) and Ovarian cancer diagnosis and treatment (18 papers). Peter Cashin is often cited by papers focused on Intraperitoneal and Appendiceal Malignancies (38 papers), Appendicitis Diagnosis and Management (33 papers) and Ovarian cancer diagnosis and treatment (18 papers). Peter Cashin collaborates with scholars based in Sweden, Australia and United States. Peter Cashin's co-authors include Haile Mahteme, Peter Nygren, W. Graf, Wilhelm Graf, Ingvar Syk, Jan‐Erik Frödin, Bengt Glimelius, Malin Enblad, Michael R. Torkzad and Helgi Birgisson and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Annals of Surgery.

In The Last Decade

Peter Cashin

40 papers receiving 614 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Cashin Sweden 14 560 406 259 63 56 42 623
Geert A. Simkens Netherlands 13 471 0.8× 321 0.8× 160 0.6× 55 0.9× 58 1.0× 26 501
Jean‐Marc Guilloit France 7 709 1.3× 485 1.2× 280 1.1× 106 1.7× 90 1.6× 11 825
Salvatore Virzì Italy 13 637 1.1× 413 1.0× 335 1.3× 48 0.8× 65 1.2× 29 703
Koen P. Rovers Netherlands 16 458 0.8× 253 0.6× 190 0.7× 86 1.4× 113 2.0× 36 571
Marcello Guagliò Italy 16 667 1.2× 417 1.0× 248 1.0× 48 0.8× 104 1.9× 62 789
Manuela Robella Italy 13 416 0.7× 245 0.6× 184 0.7× 77 1.2× 43 0.8× 44 513
C. Demtröder Germany 10 562 1.0× 316 0.8× 211 0.8× 120 1.9× 58 1.0× 14 611
Alexander Kerscher Germany 11 430 0.8× 233 0.6× 160 0.6× 44 0.7× 99 1.8× 20 535
Ángela Casado-Adam Spain 15 469 0.8× 259 0.6× 223 0.9× 37 0.6× 90 1.6× 30 577
Nathalie Laplace France 8 412 0.7× 177 0.4× 154 0.6× 75 1.2× 43 0.8× 16 483

Countries citing papers authored by Peter Cashin

Since Specialization
Citations

This map shows the geographic impact of Peter Cashin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Cashin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Cashin more than expected).

Fields of papers citing papers by Peter Cashin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Cashin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Cashin. The network helps show where Peter Cashin may publish in the future.

Co-authorship network of co-authors of Peter Cashin

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Cashin. A scholar is included among the top collaborators of Peter Cashin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Cashin. Peter Cashin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Enblad, Malin, et al.. (2025). Patterns of Preoperative Tumor Markers Can Predict Resectability and Prognosis of Peritoneal Metastases: A Clustering Analysis. Annals of Surgical Oncology. 32(5). 3638–3647. 2 indexed citations
2.
Palmer, Gabriella Jansson, Per J. Nilsson, Caroline Nordenvall, et al.. (2024). Efficacy of hyperthermic intraperitoneal chemotherapy in colorectal cancer: A phase I and III open label randomized controlled registry-based clinical trial protocol. PLoS ONE. 19(3). e0294018–e0294018. 1 indexed citations
3.
Cashin, Peter, Dan Asplund, Elinor Bexe Lindskog, et al.. (2024). Secondary cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent colorectal peritoneal metastases. Surgery Open Science. 20. 45–50. 1 indexed citations
4.
Semenas, Egidijus, et al.. (2023). The impact on postoperative outcomes of intraoperative fluid management strategies during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. European Journal of Surgical Oncology. 49(8). 1474–1480. 2 indexed citations
5.
Larsen, Stein Gunnar, et al.. (2023). 15-month safety and efficacy data after intraperitoneal treatment with 224Radium-labelled microparticles after CRS-HIPEC for peritoneal metastasis from colorectal cancer.. Journal of Clinical Oncology. 41(16_suppl). 3518–3518. 1 indexed citations
7.
Cashin, Peter, Jesús Esquivel, Stein Gunnar Larsen, et al.. (2022). Perioperative chemotherapy in colorectal cancer with peritoneal metastases: a global propensity score matched study. EClinicalMedicine. 55. 101746–101746. 13 indexed citations
9.
Mercier, Frédéric, Guillaume Passot, Pierre‐Emmanuel Bonnot, et al.. (2022). An International Registry of Peritoneal Carcinomatosis from Appendiceal Goblet Cell Carcinoma Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. World Journal of Surgery. 46(6). 1336–1343. 2 indexed citations
11.
Mahteme, Haile, et al.. (2021). Coagulopathy and Venous Thromboembolic Events Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. Annals of Surgical Oncology. 28(12). 7772–7782. 9 indexed citations
13.
Birgisson, Helgi, et al.. (2020). Patients with colorectal peritoneal metastases and high peritoneal cancer index may benefit from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. European Journal of Surgical Oncology. 46(12). 2283–2291. 20 indexed citations
14.
Graf, Wilhelm, Peter Cashin, Malin Enblad, et al.. (2019). Prognostic Impact of BRAF and KRAS Mutation in Patients with Colorectal and Appendiceal Peritoneal Metastases Scheduled for CRS and HIPEC. Annals of Surgical Oncology. 27(1). 293–300. 46 indexed citations
15.
Cashin, Peter, Haile Mahteme, Ingvar Syk, et al.. (2018). Quality of life and cost effectiveness in a randomized trial of patients with colorectal cancer and peritoneal metastases. European Journal of Surgical Oncology. 44(7). 983–990. 13 indexed citations
16.
Cashin, Peter, Wilhelm Graf, Peter Nygren, & Haile Mahteme. (2013). Comparison of Prognostic Scores for Patients with Colorectal Cancer Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. Annals of Surgical Oncology. 20(13). 4183–4189. 26 indexed citations
17.
Cashin, Peter, et al.. (2013). Activity ex vivo of cytotoxic drugs in patient samples of peritoneal carcinomatosis with special focus on colorectal cancer. BMC Cancer. 13(1). 435–435. 13 indexed citations
18.
Cashin, Peter, Wilhelm Graf, Peter Nygren, & Haile Mahteme. (2012). Patient Selection for Cytoreductive Surgery in Colorectal Peritoneal Carcinomatosis Using Serum Tumor Markers. Annals of Surgery. 256(6). 1078–1083. 39 indexed citations
19.
Cashin, Peter, Hans Ehrsson, Inger Wallin, Peter Nygren, & Haile Mahteme. (2012). Pharmacokinetics of cisplatin during hyperthermic intraperitoneal treatment of peritoneal carcinomatosis. European Journal of Clinical Pharmacology. 69(3). 533–540. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026